ITU Unit Action

NEXTJECT

Hospira, Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 86717369 FILING DATE 08/06/2015
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY LORENZO, GEORGE M
L.O. ASSIGNED 101

PUB INFORMATION

RUN DATE 08/13/2016
PUB DATE 12/22/2015
STATUS 730-FIRST EXTENSION - GRANTED
STATUS DATE 08/11/2016
LITERAL MARK ELEMENT NEXTJECT

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT NEXTJECT
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Hospira, Inc.
ADDRESS Dept. NLEG, Bldg. H-1
275 North Field Drive
Lake Forest, IL 60045
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pre-filled syringes sold filled with pharmaceutical preparations, namely, anesthetics, contrast agents for ultrasound, CT, and MRI diagnostic imaging procedures, sedatives, anti-infectives, cardiovascular pharmaceuticals, and anti-emetics, and diluents

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
PSEUDO MARK NEXT JECT

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
08/13/2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 015
08/11/2016 EX1G S EXTENSION 1 GRANTED 014
08/11/2016 EXT1 S EXTENSION 1 FILED 013
08/11/2016 EEXT I TEAS EXTENSION RECEIVED 012
02/16/2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 011
12/22/2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 010
12/22/2015 PUBO A PUBLISHED FOR OPPOSITION 009
12/02/2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 008
11/25/2015 ARAA I ATTORNEY REVOKED AND/OR APPOINTED 007
11/25/2015 REAP I TEAS REVOKE/APPOINT ATTORNEY RECEIVED 006
11/16/2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 005
11/12/2015 DOCK D ASSIGNED TO EXAMINER 004
08/13/2015 MPMK E NOTICE OF PSEUDO MARK E-MAILED 003
08/12/2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
08/10/2015 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Richard A. Friedman
CORRESPONDENCE ADDRESS Richard A. Friedman
Pfizer Inc.
235 East 42nd Street
New York NY 10017-5703
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Hospira, Inc.
ADDRESS Dept. NLEG, Bldg. H-1
275 North Field Drive
Lake Forest, IL 60045
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed